Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
Project Number1I01BX004825-01
Contact PI/Project LeaderFLECKENSTEIN, JAMES MICHAEL
Awardee OrganizationST. LOUIS VA MEDICAL CENTER
Description
Abstract Text
Enterotoxigenic Escherichia coli (ETEC) are an extraordinarily common cause of
infectious diarrhea in resource limited areas of the planet where military personnel are
frequently deployed. In endemic areas these pathogens are a major cause of morbidity
as well as mortality in young children. The acute illness associated with these
pathogens may range from mild diarrhea to severe, cholera-like disease associated with
rapid dehydration. Travelers and military personnel deployed to endemic regions are
highly susceptible to symptomatic illness caused by ETEC. Currently there is no vaccine
to prevent these infections. In addition to the acute illness these pathogens are
associated with a number of important but poorly understood sequelae including
malabsorption and tropical enteropathy, growth stunting, and cognitive impairment in
children as well as tropical malabsorption syndromes and irritable bowel syndrome in
returning travelers.
ETEC are defined by the production of enterotoxins that lead to net export of salt
and water into the intestinal lumen. Most prior research effort has focused almost
exclusively on the cellular effects of these toxins that lead to diarrhea. However, recent
transcriptome studies of host cells following infection or treatment with toxin suggest
that these enterotoxins may impart many collateral effects relevant to our understanding
of key aspects of virulence associated with acute illness as well as the sequelae
associated with these infections. The proposed studies will focus on the interaction of
highly conserved E. coli fimbriae with a family of cell surface glycoproteins related to
carcinoembryonic antigen (CEA), the carcinoembryonic antigen cell adhesion molecules
(CEACAMs) that are expressed on intestinal epithelia. Interestingly our studies
demonstrate that these molecules are strongly up-regulated by ETEC heat-labile toxin
and that they may serve as a receptor for ETEC. Because these molecules play
essential roles in cellular adhesion and maintenance of tissue architecture, modulation
of their expression could play important roles in the sequelae associated with these
infections.
Public Health Relevance Statement
Enterotoxigenic Escherichia coli (ETEC) are a common cause of diarrheal disease throughout regions
of the world were basic sanitation and clean water remain in limited supply. These infections have also
emerged repeatedly in the United States, often in the form of large outbreaks despite robust sanitation.
ETEC is the most common cause of diarrheal illness of soldiers deployed to developing regions of the
world where these infections are highly endemic. Both nonimmune children living in these areas and
returning veterans frequently experience symptoms that linger long after the diarrheal illness is gone.
Many features of the acute illness, that may be severe and indistinguishable from cholera, as well as
the subsequent illnesses that persist after the diarrhea has resolved still remain very poorly
understood. Understanding how ETEC interact with the intestine and the changes in the intestinal lining
caused by these infections could speed the development of treatment or prevention strategies.
No Sub Projects information available for 1I01BX004825-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1I01BX004825-01
Patents
No Patents information available for 1I01BX004825-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1I01BX004825-01
Clinical Studies
No Clinical Studies information available for 1I01BX004825-01
News and More
Related News Releases
No news release information available for 1I01BX004825-01
History
No Historical information available for 1I01BX004825-01
Similar Projects
No Similar Projects information available for 1I01BX004825-01